Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Feb 28, 2013Agenus to Host Conference Call Beginning at 11 a.m. ET Today
Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business...
-
Feb 27, 2013HerpV is clinically the most advanced therapeutic vaccine for the treatment of genital herpes
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced it has completed patient screening in its Phase 2 randomized, double-blind,...
-
Feb 26, 2013
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the Cowen and Company 33rd Annual...
-
Feb 21, 2013
Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and year ended December 31, 2012 financial results before the market opens on February 28, 2013. Agenus executives will host a conference...
